Pharma Journalist -

Horizon Therapeutics plc announced that it has entered a multi-year scientific collaboration with Johns Hopkins University School of Medicine to identify new disease targets and develop…
Read More...

Ascletis Pharma Inc. announces the approval of the Investigational New Drug (IND) application by China National Medical Products Administration (NMPA) for the in-house developed oral…
Read More...

Idorsia Ltd, specialized in the discovery, development and commercialization of small molecules to transform the horizon of therapeutic options, and Simcere Pharmaceutical Group Ltd, an…
Read More...

Ferring Pharmaceuticals and Gubra entered into a collaboration agreement to further develop and characterize preclinical animal models of inflammatory bowel disease (IBD). The…
Read More...

ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering transformative cell and gene therapies, and Affini-T Therapeutics, a biotechnology company unlocking the…
Read More...

NextCure, Inc. and LegoChem Biosciences, Inc. announced a collaboration and co-development agreement focused on generating a B7-H4 antibody drug conjugate (ADC) and options for two…
Read More...

Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, announced the company has…
Read More...

Exscientia plc and The University of Texas MD Anderson Cancer Center announced a strategic collaboration to align the patient-centric artificial intelligence (AI) capabilities of…
Read More...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a new collaboration with Rimidi, a leading clinical management platform designed to optimize…
Read More...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the treatment of adult patients with…
Read More...